|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 570 for Tsc2

<< First    < Previous  |  Next >    Last >>
0.048s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Gene
Type: gene
Organism: Homo sapiens
Gene
Type: gene
Organism: Rattus norvegicus
Gene
Type: gene
Organism: Danio rerio
HT Sample          
Organism Name: mouse, laboratory
Curation Status: Not curated (Transgenic sample)
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus musculus
Publication
First Author: Pollizzi K
Year: 2009
Journal: Hum Mol Genet
Title: A hypomorphic allele of Tsc2 highlights the role of TSC1/TSC2 in signaling to AKT and models mild human TSC2 alleles.
Volume: 18
Issue: 13
Pages: 2378-87
Publication
First Author: Hernandez O
Year: 2007
Journal: Genesis
Title: Generation of a conditional disruption of the Tsc2 gene.
Volume: 45
Issue: 2
Pages: 101-6
Publication
First Author: Ogórek B
Year: 2018
Journal: Hum Mol Genet
Title: TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β.
Volume: 27
Issue: 9
Pages: 1654-1663
Publication
First Author: Ranek MJ
Year: 2019
Journal: Nature
Title: PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
Volume: 566
Issue: 7743
Pages: 264-269
Publication
First Author: Olsson PG
Year: 1996
Journal: Mamm Genome
Title: Expression and differential splicing of the mouse TSC2 homolog.
Volume: 7
Issue: 3
Pages: 212-5
Publication    
First Author: Klover PJ
Year: 2017
Journal: Elife
Title: Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing Lgals3.
Volume: 6
Publication  
First Author: Demetriades C
Year: 2016
Journal: Nat Commun
Title: Lysosomal recruitment of TSC2 is a universal response to cellular stress.
Volume: 7
Pages: 10662
Publication
First Author: Moir LM
Year: 2012
Journal: Am J Physiol Lung Cell Mol Physiol
Title: TSC2 modulates cell adhesion and migration via integrin-α1β1.
Volume: 303
Issue: 8
Pages: L703-10
Publication
First Author: Kuo HP
Year: 2010
Journal: Sci Signal
Title: ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway.
Volume: 3
Issue: 108
Pages: ra9
Publication
First Author: Alesi N
Year: 2021
Journal: Nat Commun
Title: TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism.
Volume: 12
Issue: 1
Pages: 4245
Publication
First Author: Fu C
Year: 2013
Journal: Genesis
Title: Conditional and domain-specific inactivation of the Tsc2 gene in neural progenitor cells.
Volume: 51
Issue: 4
Pages: 284-92
Publication
First Author: Riddle RC
Year: 2014
Journal: Mol Cell Biol
Title: Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis.
Volume: 34
Issue: 10
Pages: 1850-62
Publication
First Author: Ma L
Year: 2005
Journal: Cell
Title: Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.
Volume: 121
Issue: 2
Pages: 179-93
Publication
First Author: Rozas NS
Year: 2015
Journal: Biochem Biophys Res Commun
Title: Prolonging the survival of Tsc2 conditional knockout mice by glutamine supplementation.
Volume: 457
Issue: 4
Pages: 635-9
Publication
First Author: García-Aguilar A
Year: 2016
Journal: Biochim Biophys Acta
Title: TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy.
Volume: 1863
Issue: 11
Pages: 2658-2667
Publication  
First Author: Crowell B
Year: 2015
Journal: eNeuro
Title: Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123).
Volume: 2
Issue: 6
Publication
First Author: Prizant H
Year: 2013
Journal: Mol Endocrinol
Title: Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs.
Volume: 27
Issue: 9
Pages: 1403-14
Publication
First Author: Pasumarthi KB
Year: 2000
Journal: Circ Res
Title: Enhanced cardiomyocyte DNA synthesis during myocardial hypertrophy in mice expressing a modified TSC2 transgene.
Volume: 86
Issue: 10
Pages: 1069-77
Publication
First Author: Mietzsch U
Year: 2013
Journal: J Comp Neurol
Title: Comparative analysis of Tsc1 and Tsc2 single and double radial glial cell mutants.
Volume: 521
Issue: 16
Pages: 3817-31
Publication
First Author: Koyanagi M
Year: 2011
Journal: PLoS One
Title: Ablation of TSC2 enhances insulin secretion by increasing the number of mitochondria through activation of mTORC1.
Volume: 6
Issue: 8
Pages: e23238
Publication
First Author: Nellist M
Year: 2001
Journal: Hum Mol Genet
Title: TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex.
Volume: 10
Issue: 25
Pages: 2889-98
Publication
First Author: Van Nostrand JL
Year: 2020
Journal: Genes Dev
Title: AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation.
Volume: 34
Issue: 19-20
Pages: 1330-1344
Publication
First Author: Ren S
Year: 2016
Journal: Am J Pathol
Title: Inactivation of Tsc2 in Mesoderm-Derived Cells Causes Polycystic Kidney Lesions and Impairs Lung Alveolarization.
Volume: 186
Issue: 12
Pages: 3261-3272
Publication
First Author: Kobayashi T
Year: 1999
Journal: Cancer Res
Title: Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice.
Volume: 59
Issue: 6
Pages: 1206-11
Publication  
First Author: Reith RM
Year: 2013
Journal: Neurobiol Dis
Title: Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex.
Volume: 51
Pages: 93-103
Publication  
First Author: Carlin D
Year: 2019
Journal: eNeuro
Title: Nociceptor Deletion of Tsc2 Enhances Axon Regeneration by Inducing a Conditioning Injury Response in Dorsal Root Ganglia.
Volume: 6
Issue: 3
Publication
First Author: M A S
Year: 2019
Journal: Carcinogenesis
Title: Heterozygous Tsc2 (Tsc2+/-) mouse model to study induced renal cancer in response to ionizing radiation at low doses.
Volume: 40
Issue: 6
Pages: 782-790
Publication  
First Author: Carlin D
Year: 2018
Journal: eNeuro
Title: Deletion of Tsc2 in Nociceptors Reduces Target Innervation, Ion Channel Expression, and Sensitivity to Heat.
Volume: 5
Issue: 2
Publication
First Author: Onda H
Year: 2002
Journal: Mol Cell Neurosci
Title: Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway.
Volume: 21
Issue: 4
Pages: 561-74
Publication
First Author: Ma L
Year: 2005
Journal: Genes Dev
Title: Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression.
Volume: 19
Issue: 15
Pages: 1779-86
Publication
First Author: D'Armiento J
Year: 2016
Journal: Cancer Res
Title: Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation.
Volume: 76
Issue: 4
Pages: 844-54
Publication
First Author: Way SW
Year: 2009
Journal: Hum Mol Genet
Title: Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.
Volume: 18
Issue: 7
Pages: 1252-65
Publication
First Author: Rachdi L
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: Disruption of Tsc2 in pancreatic beta cells induces beta cell mass expansion and improved glucose tolerance in a TORC1-dependent manner.
Volume: 105
Issue: 27
Pages: 9250-5
Publication
First Author: Zeng LH
Year: 2011
Journal: Hum Mol Genet
Title: Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
Volume: 20
Issue: 3
Pages: 445-54
Publication
First Author: Kang YJ
Year: 2011
Journal: Cell Death Differ
Title: The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis.
Volume: 18
Issue: 1
Pages: 133-44
Publication
First Author: Jacobs BL
Year: 2013
Journal: J Physiol
Title: Eccentric contractions increase the phosphorylation of tuberous sclerosis complex-2 (TSC2) and alter the targeting of TSC2 and the mechanistic target of rapamycin to the lysosome.
Volume: 591
Issue: 18
Pages: 4611-20
Publication
First Author: Kobayashi T
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice.
Volume: 98
Issue: 15
Pages: 8762-7
Publication
First Author: Gewin LS
Year: 2019
Journal: Am J Physiol Renal Physiol
Title: Inactivation of Tsc2 in Abcg2 lineage-derived cells drives the appearance of polycystic lesions and fibrosis in the adult kidney.
Volume: 317
Issue: 5
Pages: F1201-F1210
Publication
First Author: Ma J
Year: 2010
Journal: J Clin Invest
Title: Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade.
Volume: 120
Issue: 1
Pages: 103-14
Publication
First Author: Xu L
Year: 1995
Journal: Genomics
Title: Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues.
Volume: 27
Issue: 3
Pages: 475-80
Publication
First Author: Yuan E
Year: 2012
Journal: Hum Mol Genet
Title: Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features.
Volume: 21
Issue: 19
Pages: 4286-300
Publication
First Author: Chévere-Torres I
Year: 2012
Journal: Neurobiol Dis
Title: Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex.
Volume: 45
Issue: 3
Pages: 1101-10
Publication
First Author: Di Nardo A
Year: 2020
Journal: Cell Rep
Title: Phenotypic Screen with TSC-Deficient Neurons Reveals Heat-Shock Machinery as a Druggable Pathway for mTORC1 and Reduced Cilia.
Volume: 31
Issue: 12
Pages: 107780
Publication
First Author: Cheadle JP
Year: 2000
Journal: Hum Genet
Title: Molecular genetic advances in tuberous sclerosis.
Volume: 107
Issue: 2
Pages: 97-114
Publication
First Author: Kawakami S
Year: 1998
Journal: Mamm Genome
Title: Tctex3, related to Drosophila polycomblike, is expressed in male germ cells and mapped to the mouse t-complex.
Volume: 9
Issue: 11
Pages: 874-80
Publication  
First Author: Rushing GV
Year: 2019
Journal: Life Sci Alliance
Title: Location-dependent maintenance of intrinsic susceptibility to mTORC1-driven tumorigenesis.
Volume: 2
Issue: 2
Publication
First Author: Lou D
Year: 2001
Journal: Mol Cell Biol Res Commun
Title: The tuberous sclerosis 2 gene product can localize to nuclei in a phosphorylation-dependent manner.
Volume: 4
Issue: 6
Pages: 374-80
Publication
First Author: Zhang J
Year: 2013
Journal: Nat Cell Biol
Title: A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS.
Volume: 15
Issue: 10
Pages: 1186-96
Publication
First Author: Kim KK
Year: 1995
Journal: Cell Mol Biol Res
Title: Cloning, developmental expression, and evidence for alternative splicing of the murine tuberous sclerosis (TSC2) gene product.
Volume: 41
Issue: 6
Pages: 515-26
Publication
First Author: Shigeyama Y
Year: 2008
Journal: Mol Cell Biol
Title: Biphasic response of pancreatic beta-cell mass to ablation of tuberous sclerosis complex 2 in mice.
Volume: 28
Issue: 9
Pages: 2971-9
Publication
First Author: Nie D
Year: 2010
Journal: Nat Neurosci
Title: Tsc2-Rheb signaling regulates EphA-mediated axon guidance.
Volume: 13
Issue: 2
Pages: 163-72
Publication
First Author: Linke M
Year: 2017
Journal: Nat Immunol
Title: Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression.
Volume: 18
Issue: 3
Pages: 293-302
Publication
First Author: Way SW
Year: 2012
Journal: Hum Mol Genet
Title: The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex.
Volume: 21
Issue: 14
Pages: 3226-36
Publication
First Author: McKenna J 3rd
Year: 2018
Journal: Hum Mol Genet
Title: Metabolomic studies identify changes in transmethylation and polyamine metabolism in a brain-specific mouse model of tuberous sclerosis complex.
Volume: 27
Issue: 12
Pages: 2113-2124
Publication
First Author: Onda H
Year: 1999
Journal: J Clin Invest
Title: Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.
Volume: 104
Issue: 6
Pages: 687-95
Publication
First Author: Reith RM
Year: 2011
Journal: Neurobiol Dis
Title: Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration.
Volume: 43
Issue: 1
Pages: 113-22
Publication
First Author: Mak BC
Year: 2005
Journal: Am J Pathol
Title: Aberrant beta-catenin signaling in tuberous sclerosis.
Volume: 167
Issue: 1
Pages: 107-16
Publication  
First Author: Saré RM
Year: 2020
Journal: eNeuro
Title: Sex-Selective Effects on Behavior in a Mouse Model of Tuberous Sclerosis Complex.
Volume: 7
Issue: 2
Publication
First Author: Huang J
Year: 2009
Journal: Cancer Res
Title: Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors.
Volume: 69
Issue: 15
Pages: 6107-14
Publication  
First Author: Okamoto SI
Year: 2019
Journal: Neurobiol Dis
Title: NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model.
Volume: 127
Pages: 390-397
Publication  
First Author: Pollizzi K
Year: 2009
Journal: Mol Cancer
Title: Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis.
Volume: 8
Pages: 38
Publication
First Author: Brown AB
Year: 2005
Journal: Hum Gene Ther
Title: Magnetic resonance imaging and characterization of spontaneous lesions in a transgenic mouse model of tuberous sclerosis as a model for endothelial cell-based transgene delivery.
Volume: 16
Issue: 12
Pages: 1367-76
Publication
First Author: Young DM
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism.
Volume: 107
Issue: 24
Pages: 11074-9
Publication
First Author: Guo Y
Year: 2013
Journal: Mol Cancer Res
Title: Equivalent benefit of rapamycin and a potent mTOR ATP-competitive inhibitor, MLN0128 (INK128), in a mouse model of tuberous sclerosis.
Volume: 11
Issue: 5
Pages: 467-73
Publication
First Author: Cao J
Year: 2010
Journal: Hum Mol Genet
Title: Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice.
Volume: 19
Issue: 10
Pages: 1908-20
Publication
First Author: Auricchio N
Year: 2012
Journal: PLoS One
Title: Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC).
Volume: 7
Issue: 2
Pages: e31900
Publication
First Author: Hobbs RM
Year: 2015
Journal: EMBO Rep
Title: Distinct germline progenitor subsets defined through Tsc2-mTORC1 signaling.
Volume: 16
Issue: 4
Pages: 467-80
Publication
First Author: Goncharova EA
Year: 2012
Journal: Sci Transl Med
Title: Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM).
Volume: 4
Issue: 154
Pages: 154ra134
Publication
First Author: Tsai V
Year: 2014
Journal: Cereb Cortex
Title: Fetal brain mTOR signaling activation in tuberous sclerosis complex.
Volume: 24
Issue: 2
Pages: 315-27
Publication
First Author: Shi Q
Year: 2018
Journal: Sci Rep
Title: Nox4 is a Target for Tuberin Deficiency Syndrome.
Volume: 8
Issue: 1
Pages: 3781
Publication
First Author: Manning BD
Year: 2005
Journal: Genes Dev
Title: Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.
Volume: 19
Issue: 15
Pages: 1773-8
Publication
First Author: Simckes AM
Year: 2002
Journal: Cytogenet Genome Res
Title: Chromosomal localization of three vacuolar-H+ -ATPase 16 kDa subunit (ATP6V0C) genes in the murine genome.
Volume: 97
Issue: 1-2
Pages: 111-5
Publication
First Author: Kwiatkowski DJ
Year: 2002
Journal: Hum Mol Genet
Title: A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.
Volume: 11
Issue: 5
Pages: 525-34
Publication
First Author: Ebrahimi-Fakhari D
Year: 2016
Journal: Cell Rep
Title: Impaired Mitochondrial Dynamics and Mitophagy in Neuronal Models of Tuberous Sclerosis Complex.
Volume: 17
Issue: 4
Pages: 1053-1070
Publication
First Author: Bartolomé A
Year: 2014
Journal: Diabetes
Title: Pancreatic β-cell failure mediated by mTORC1 hyperactivity and autophagic impairment.
Volume: 63
Issue: 9
Pages: 2996-3008
Publication
First Author: Tang G
Year: 2014
Journal: Neuron
Title: Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.
Volume: 83
Issue: 5
Pages: 1131-43
Publication
First Author: Yang F
Year: 2018
Journal: J Invest Dermatol
Title: Uncoupling of ER/Mitochondrial Oxidative Stress in mTORC1 Hyperactivation-Associated Skin Hypopigmentation.
Volume: 138
Issue: 3
Pages: 669-678
Publication
First Author: Yang F
Year: 2020
Journal: PLoS One
Title: Epilepsy in a melanocyte-lineage mTOR hyperactivation mouse model: A novel epilepsy model.
Volume: 15
Issue: 1
Pages: e0228204
Publication
First Author: Olsson PG
Year: 1996
Journal: Genomics
Title: The mouse homologue of the polycystic kidney disease gene (Pkd1) is a single-copy gene.
Volume: 34
Issue: 2
Pages: 233-5
Publication
First Author: Sun Y
Year: 2014
Journal: Am J Respir Cell Mol Biol
Title: Rapamycin-resistant poly (ADP-ribose) polymerase-1 overexpression is a potential therapeutic target in lymphangioleiomyomatosis.
Volume: 51
Issue: 6
Pages: 738-49
Publication
First Author: Bernardi R
Year: 2011
Journal: EMBO Mol Med
Title: Pml represses tumour progression through inhibition of mTOR.
Volume: 3
Issue: 5
Pages: 249-57
Publication
First Author: Dibble CC
Year: 2012
Journal: Mol Cell
Title: TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.
Volume: 47
Issue: 4
Pages: 535-46
Publication
First Author: Lipton JO
Year: 2017
Journal: Cell Rep
Title: Aberrant Proteostasis of BMAL1 Underlies Circadian Abnormalities in a Paradigmatic mTOR-opathy.
Volume: 20
Issue: 4
Pages: 868-880
Publication
First Author: Wang F
Year: 2014
Journal: Oncogene
Title: Pivotal role of augmented αB-crystallin in tumor development induced by deficient TSC1/2 complex.
Volume: 33
Issue: 34
Pages: 4352-8
Publication
First Author: Ozcan U
Year: 2008
Journal: Mol Cell
Title: Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis.
Volume: 29
Issue: 5
Pages: 541-51
Publication
First Author: Kapfhamer D
Year: 2020
Journal: Hum Mol Genet
Title: Ornithine decarboxylase, the rate-limiting enzyme of polyamine synthesis, modifies brain pathology in a mouse model of tuberous sclerosis complex.
Volume: 29
Issue: 14
Pages: 2395-2407
Publication
First Author: Habib SL
Year: 2008
Journal: Am J Physiol Renal Physiol
Title: Tuberin regulates the DNA repair enzyme OGG1.
Volume: 294
Issue: 1
Pages: F281-90
Publication  
First Author: Woodrum C
Year: 2010
Journal: J Transl Med
Title: Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors.
Volume: 8
Pages: 14
Publication  
First Author: Sugiura H
Year: 2015
Journal: Nat Commun
Title: Rheb activation disrupts spine synapse formation through accumulation of syntenin in tuberous sclerosis complex.
Volume: 6
Pages: 6842
Publication
First Author: Ghosh HS
Year: 2010
Journal: PLoS One
Title: SIRT1 negatively regulates the mammalian target of rapamycin.
Volume: 5
Issue: 2
Pages: e9199
Publication
First Author: Choi YJ
Year: 2008
Journal: Genes Dev
Title: Tuberous sclerosis complex proteins control axon formation.
Volume: 22
Issue: 18
Pages: 2485-95
Publication  
First Author: Sato A
Year: 2012
Journal: Nat Commun
Title: Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex.
Volume: 3
Pages: 1292
Publication
First Author: Gilbert ER
Year: 2013
Journal: Am J Pathol
Title: Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis.
Volume: 183
Issue: 1
Pages: 226-34
Publication
First Author: Du H
Year: 2018
Journal: Hum Mol Genet
Title: A novel mouse model of hemangiopericytoma due to loss of Tsc2.
Volume: 27
Issue: 24
Pages: 4169-4175
Publication
First Author: Wang CY
Year: 2012
Journal: J Lipid Res
Title: Tsc2, a positional candidate gene underlying a quantitative trait locus for hepatic steatosis.
Volume: 53
Issue: 8
Pages: 1493-501